Latest & greatest articles for influenza

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on influenza or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on influenza and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for influenza

1. Influenza: treatment and prophylaxis using anti-viral agents

Influenza: treatment and prophylaxis using anti-viral agents Influenza: treatment and prophylaxis using anti-viral agents - GOV.UK GOV.UK uses cookies which are essential for the site to work. We also use non-essential cookies to help us improve government digital services. Any data collected is anonymised. By continuing to use this site, you agree to our use of cookies. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance Influenza: treatment and prophylaxis (...) using anti-viral agents Guidance on how to manage influenza (flu) using anti-viral agents. Published 23 January 2014 Last updated 8 October 2019 — From: Documents Ref: PHE publications gateway number: GW-685 If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what format you need. It will help us if you say what assistive technology you use. Ref: 2014422 If you use assistive technology

2019 Public Health England

2. Influenza-like illness (ILI): managing outbreaks in schools

Influenza-like illness (ILI): managing outbreaks in schools Influenza-like illness (ILI): managing outbreaks in schools - GOV.UK GOV.UK uses cookies which are essential for the site to work. We also use non-essential cookies to help us improve government digital services. Any data collected is anonymised. By continuing to use this site, you agree to our use of cookies. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance Influenza-like illness (ILI): managing (...) outbreaks in schools Guidance for local PHE Centre health protection teams about assessing and managing outbreaks of influenza-like illness in schools. Published 2 October 2018 Last updated 26 September 2019 — From: Documents Ref: PHE publications gateway number: GW-688 If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what format you need. It will help us if you say what assistive technology you use

2019 Public Health England

3. High Dose Influenza Vaccine for Adults: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines

High Dose Influenza Vaccine for Adults: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines High Dose Influenza Vaccine for Adults: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines | CADTH.ca Find the information you need High Dose Influenza Vaccine for Adults: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines High Dose Influenza Vaccine for Adults: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines Last updated (...) : January 8, 2019 Project Number: RC1059-000 Product Line: Research Type: Drug Report Type: Summary with Critical Appraisal Result type: Report Question What is the clinical effectiveness of high dose influenza vaccine in older adults or adults who are immunocompromised? What is the cost-effectiveness of high dose influenza vaccine in older adults or adults who are immunocompromised? What are the evidence-based guidelines associated with the use of high dose influenza vaccine in older adults or adults

2019 Canadian Agency for Drugs and Technologies in Health - Rapid Review

4. Recommendations for Prevention and Control of Influenza in Children, 2019–2020

Recommendations for Prevention and Control of Influenza in Children, 2019–2020 Recommendations for Prevention and Control of Influenza in Children, 2019–2020 | From the American Academy of Pediatrics | Pediatrics '); document.write(''); } function OAS_AD(pos) { if (OAS_version >= 11 && typeof(OAS_RICH)!='undefined') { OAS_RICH(pos); } else { OAS_NORMAL(pos); } } //--> Search for this keyword Source User menu Sections Sign up for highlighting editor-chosen studies with the greatest impact (...) on clinical care. Recommendations for Prevention and Control of Influenza in Children, 2019–2020 COMMITTEE ON INFECTIOUS DISEASES Abstract This statement updates the recommendations of the American Academy of Pediatrics for the routine use of influenza vaccines and antiviral medications in the prevention and treatment of influenza in children during the 2019–2020 season. The American Academy of Pediatrics continues to recommend routine influenza immunization of all children without medical

2019 American Academy of Pediatrics

5. Vaccine recommendations for children and youth for the 2019/2020 influenza season

Vaccine recommendations for children and youth for the 2019/2020 influenza season The Canadian Paediatric Society continues to encourage annual influenza vaccination for ALL children and youth 6 months of age and older. Recommendations from the National Advisory Committee on Immunization (NACI) for the 2019/2020 influenza season are not substantially changed from those of last season. Quadrivalent vaccine, if available, is recommended for children 6 months to 17 years of age. Either inactivated (...) influenza vaccine or live attenuated influenza vaccine may be used for children and youth 2 to 17 years of age who are not immunocompromised. However, LAIV will not be available in Canada for the 2019/2020 season. Keywords: Children; Influenza vaccine; Inactivated influenza vaccine; LAIV; NACI

2019 Canadian Paediatric Society

6. Do Corticosteroids Benefit Patients With Influenza Pneumonia?

Do Corticosteroids Benefit Patients With Influenza Pneumonia? Do Corticosteroids Benefit Patients With Influenza Pneumonia? - Annals of Emergency Medicine Email/Username: Password: Remember me Search Terms Search within Search Share this page To read this article in full, please review your options for gaining access at the bottom of the page. Article in Press Do Corticosteroids Benefit Patients With Influenza Pneumonia? x Michael Gottlieb , MD (EBEM Commentator) , x Thomas Seagraves , MD (EBEM (...) Commentator) , x Stephen R. Gore , MD (EBEM Commentator) Department of Emergency Medicine, Rush University Medical Center, Chicago, IL DOI: Publication History Published online: July 23, 2019 To view the full text, please login as a subscribed user or . Click to view the full text on ScienceDirect. Among patients with influenza pneumonia, corticosteroids are associated with increased mortality, longer length of stay in the ICU, and higher rates of secondary infection, although there are no data from

2019 Annals of Emergency Medicine Systematic Review Snapshots

7. N95 Respirators vs Medical Masks for Preventing Influenza Among Health Care Personnel: A Randomized Clinical Trial. (PubMed)

N95 Respirators vs Medical Masks for Preventing Influenza Among Health Care Personnel: A Randomized Clinical Trial. Clinical studies have been inconclusive about the effectiveness of N95 respirators and medical masks in preventing health care personnel (HCP) from acquiring workplace viral respiratory infections.To compare the effect of N95 respirators vs medical masks for prevention of influenza and other viral respiratory infections among HCP.A cluster randomized pragmatic effectiveness study (...) were randomly assigned to wear medical masks (2668 HCP-seasons) when near patients with respiratory illness.The primary outcome was the incidence of laboratory-confirmed influenza. Secondary outcomes included incidence of acute respiratory illness, laboratory-detected respiratory infections, laboratory-confirmed respiratory illness, and influenzalike illness. Adherence to interventions was assessed.Among 2862 randomized participants (mean [SD] age, 43 [11.5] years; 2369 [82.8%]) women), 2371

2019 JAMA

8. Health outcomes of young children born to mothers who received 2009 pandemic H1N1 influenza vaccination during pregnancy: retrospective cohort study. (PubMed)

Health outcomes of young children born to mothers who received 2009 pandemic H1N1 influenza vaccination during pregnancy: retrospective cohort study. To determine whether any association exists between exposure to 2009 pandemic H1N1 (pH1N1) influenza vaccination during pregnancy and negative health outcomes in early childhood.Retrospective cohort study.Population based birth registry linked with health administrative databases in the province of Ontario, Canada.All live births from November (...) , incidence rate ratios, and risk ratios for potential confounding.Of 104 249 live births, 31 295 (30%) were exposed to pH1N1 influenza vaccination in utero. No significant associations were found with upper or lower respiratory infections, otitis media, any infectious diseases, neoplasms, sensory disorders, urgent and inpatient health services use, pediatric complex chronic conditions, or mortality. A weak association was observed between prenatal pH1N1 vaccination and increased risk of asthma (adjusted

2019 BMJ

9. Influenza post exposure prophylaxis and treatment: PGD templates

Influenza post exposure prophylaxis and treatment: PGD templates Influenza post exposure prophylaxis and treatment: PGD templates - GOV.UK GOV.UK uses cookies to make the site simpler. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance Influenza post exposure prophylaxis and treatment: PGD templates Patient group direction (PGD) templates for post exposure prophylaxis and treatment of flu for adult residents and staff of care homes. Published 12 January 2016 (...) technology you use. Details These patient group direction ( 18 March 2019 Updated 'Oseltamivir' patient group direction (PGD) templates. 23 February 2019 Updated Zanamivir powder treatments for influenza guidance. 27 July 2018 Updated patient group direction (PGD) templates with latest versions. 12 January 2016 First published. Explore the topic Is this page useful? Thank you for your feedback Help us improve GOV.UK Don’t include personal or financial information like your National Insurance number

2019 Public Health England

10. Risk Assessment of Avian Influenza A(H9N2)

Risk Assessment of Avian Influenza A(H9N2) Risk Assessment of Avian Influenza A(H9N2) - GOV.UK GOV.UK uses cookies to make the site simpler. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance Risk Assessment of Avian Influenza A(H9N2) Published 20 March 2019 Contents © Crown copyright 2019 This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit or write to the Information (...) Policy Team, The National Archives, Kew, London TW9 4DU, or email: . Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned. This publication is available at https://www.gov.uk/government/publications/risk-assessment-of-avian-influenza-ah9n2/risk-assessment-of-avian-influenza-ah9n2 1. Epidemiology of A(H9N2) in humans Avian influenza A(H9N2) is a common and geographically widespread disease of birds, which has the ability

2019 Public Health England

11. Avian influenza A(H7N4): risk assessment

Avian influenza A(H7N4): risk assessment Avian influenza A(H7N4): risk assessment - GOV.UK GOV.UK uses cookies to make the site simpler. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance Avian influenza A(H7N4): risk assessment Updated 16 April 2019 Contents © Crown copyright 2019 This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit or write to the Information Policy Team (...) , The National Archives, Kew, London TW9 4DU, or email: . Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned. This publication is available at https://www.gov.uk/government/publications/avian-influenza-ah7n4-risk-assessment/avian-influenza-ah7n4-risk-assessment Public Health England’s risk assessment for H7N4 Update 12 April 2019: All risk assessments are reviewed regularly, but are not updated unless there is a significant

2019 Public Health England

12. Health Care Support Workers Administering Inactivated Influenza, Shingles and Pneumococcal Vaccines for Adults and Live Attenuated Influenza Vaccine (LAIV) for Children

Health Care Support Workers Administering Inactivated Influenza, Shingles and Pneumococcal Vaccines for Adults and Live Attenuated Influenza Vaccine (LAIV) for Children CLINICAL PROFESSIONAL RESOURCE Health Care Support Workers Administering Inactivated Influenza, Shingles and Pneumococcal Vaccines for Adults and Live Attenuated Influenza Vaccine (LAIV) for Children RCN guidance Version 3 revised 2019 This RCN document applies in England and Wales in line with the National Minimum Standards (...) (for example, the LAIV) 12 ContentsHEALTH CARE SUPPORT WORKERS ADMINISTERING VACCINES FOR ADULTS AND CHILDREN 4 This publication outlines the Royal College of Nursing’s (RCN) position on health care support workers (HCSW) administering vaccines and the role of health care professionals who support them. This publication applies to specific vaccinations given as part of the routine national schedule. These vaccines are: • the delivery of the influenza, pneumococcal and shingles vaccines given to adults

2019 Royal College of Nursing

13. Association between inactivated influenza vaccine and primary care consultations for autoimmune rheumatic disease flares: a self-controlled case series study using data from the Clinical Practice Research Datalink

Association between inactivated influenza vaccine and primary care consultations for autoimmune rheumatic disease flares: a self-controlled case series study using data from the Clinical Practice Research Datalink ObjectivesTo examine the association between inactivated influenza vaccine (IIV) administration and primary care consultation for joint pain, rheumatoid arthritis (RA) flare, corticosteroid prescription, vasculitis and unexplained fever in people with autoimmune rheumatic diseases (...) (AIRDs).We undertook within-person comparisons using self-controlled case-series methodology. AIRD cases who received the IIV and had an outcome of interest in the same influenza cycle were ascertained in Clinical Practice Research Datalink. The influenza cycle was partitioned into exposure periods (1-14 days prevaccination and 0-14, 15-30, 31-60 and 61-90 days postvaccination), with the remaining time-period classified as non-exposed. Incidence rate ratios (IRR) and 95% CI for different outcomes

2019 EvidenceUpdates

14. Comparative Immunogenicity of Enhanced Seasonal Influenza Vaccines in Older Adults: A Systematic Review and Meta-analysis

Comparative Immunogenicity of Enhanced Seasonal Influenza Vaccines in Older Adults: A Systematic Review and Meta-analysis A number of enhanced influenza vaccines have been developed for use in older adults, including high-dose, MF59-adjuvanted, and intradermal vaccines.We conducted a systematic review examining the improvements in antibody responses measured by the hemagglutination inhibition assay associated with these enhanced vaccines, compared with each other and with the standard-dose (SD

2019 EvidenceUpdates

15. Influenza infection

Influenza infection Influenza infection - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Influenza infection Last reviewed: February 2019 Last updated: March 2019 Summary Characterised by upper and lower respiratory tract symptoms of rhinorrhoea, cough, fever, chills, headache, and myalgia. Typically presents in winter season. Can occur in local community outbreaks, epidemics, and, rarely, pandemics. Vaccination (...) for prevention is available. Definition Acute respiratory tract infection typically caused by seasonal influenza A or B virus. The virus is transmitted by inhalation of infected respiratory secretions that have been aerosolised through coughing, sneezing, or talking. Brankston G, Gitterman L, Hirji Z, et al. Transmission of influenza A in human beings. Lancet Infect Dis. 2007;7:257-265. http://www.ncbi.nlm.nih.gov/pubmed/17376383?tool=bestpractice.com History and exam winter season current influenza outbreak

2019 BMJ Best Practice

16. Corticosteroids as adjunctive therapy in the treatment of influenza. (PubMed)

Corticosteroids as adjunctive therapy in the treatment of influenza. Specific treatments for influenza are limited to neuraminidase inhibitors and adamantanes. Corticosteroids show evidence of benefit in sepsis and related conditions, most likely due to their anti-inflammatory and immunomodulatory properties. Although commonly prescribed for severe influenza, there is uncertainty over their potential benefits or harms. This is an update of a review first published in 2016.To systematically (...) assess the effectiveness and potential adverse effects of corticosteroids as adjunctive therapy in the treatment of influenza, taking into account differences in timing and doses of corticosteroids.We searched CENTRAL (2018, Issue 9), which includes the Cochrane Acute Respiratory infections Group's Specialised Register, MEDLINE (1946 to October week 1, 2018), Embase (1980 to 3 October 2018), CINAHL (1981 to 3 October 2018), LILACS (1982 to 3 October 2018), Web of Science (1985 to 3 October 2018

Full Text available with Trip Pro

2019 Cochrane

17. Adult Outpatients With Acute Cough Due to Suspected Pneumonia or Influenza: CHEST Guideline and Expert Panel Report

Adult Outpatients With Acute Cough Due to Suspected Pneumonia or Influenza: CHEST Guideline and Expert Panel Report Patients commonly present to primary care services with upper and lower respiratory tract infections, and guidelines to help physicians investigate and treat acute cough due to suspected pneumonia and influenza are needed.A systematic search was carried out with eight patient, intervention, comparison, outcome questions related to acute cough due to suspected pneumonia (...) or influenza.There was a lack of randomized controlled trials in the setting of outpatients presenting with acute cough due to suspected pneumonia or influenza who were not hospitalized. Both clinical suggestions and research recommendations were made on the evidence available and CHEST Expert Cough Panel advice.For outpatient adults with acute cough due to suspected pneumonia, we suggest the following clinical symptoms and signs are suggestive of pneumonia: cough; dyspnea; pleural pain; sweating, fevers

2019 EvidenceUpdates

18. Seasonal influenza vaccination of health care workers: evidence synthesis

Seasonal influenza vaccination of health care workers: evidence synthesis influenza vaccination 18 March 2019 Links Download reports (pdf) Seasonal influenza vaccination of health care workers: evidence synthesis What do we want to know? This review addresses the following questions: What are the views and experiences of healthcare workers (HCWs) regarding vaccination for seasonal influenza? What is known about the implementation and context of interventions to promote vaccination for seasonal (...) influenza among HCWs? Who wants to know and why? This systematic review provides policy-makers and people involved in delivering vaccination promotion interventions with an overview of what is known about HCWs’ perceptions and attitudes. The focus on qualitative evidence and contextual data from intervention studies can help us to understand what problems may be encountered in implementing interventions, and also to gain a broader and more critical understanding of the contexts of vaccination promotion

2019 EPPI Centre

19. 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenza

2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenza Influenza Search Search Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenza Published : 19 December 2018 Timothy M. Uyeki, Henry H. Bernstein, John S. Bradley, Janet A. Englund, Thomas M. File Jr, Alicia M. Fry, Stefan Gravenstein, Frederick G (...) . Hayden, Scott A. Harper, Jon Mark Hirshon, Michael G. Ison, B. Lynn Johnston, Shandra L. Knight, Allison McGeer, Laura E. Riley, Cameron R. Wolfe, Paul E. Alexander, and Andrew T. Pavia For full document, including tables and references, please visit the . Abstract These clinical practice guidelines are an update of the guidelines published by the Infectious Diseases Society of America (IDSA) in 2009, prior to the 2009 H1N1 influenza pandemic. This document addresses new information regarding

2019 Infectious Diseases Society of America

20. The use and effectiveness of oseltamivir in influenza-related respiratory infections in people with chronic cardiac and pulmonary disease: a systematic review and meta-analysis of randomized controlled trials and observational studies

The use and effectiveness of oseltamivir in influenza-related respiratory infections in people with chronic cardiac and pulmonary disease: a systematic review and meta-analysis of randomized controlled trials and observational studies Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission

2019 PROSPERO